IKT
Inhibikase Therapeutics Inc
2.00$
+3.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.2% | 98.0% | 97.6% | 97.5% | 95.7% | 99.8% | 99.9% | 99.9% | 98.7% | 99.4% | 99.3% | 99.2% | |
| 83.1% | 63.2% | 21.3% | 35.0% | 20.9% | 57.3% | 77.9% | 87.5% | 48.1% | 76.8% | 28.6% | 19.1% | |
| 94.1% | 91.4% | 88.1% | 90.0% | 74.1% | 98.9% | 98.8% | 98.7% | 97.1% | 98.7% | 98.3% | 97.2% | |
| 0.2% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 6.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 16.0% | 24.3% | 38.8% | 42.3% | 112.1% | 3.8% | 9.1% | 9.9% | 8.4% | 4.6% | 3.3% | 6.3% | |
| 15.3% | 23.7% | 38.2% | 42.0% | 112.1% | 3.8% | 9.1% | 9.9% | 8.4% | 4.6% | 3.3% | 6.3% | |
| 0.8% | 3.7% | 3.9% | 3.7% | 5.0% | 0.1% | 0.1% | 0.0% | – | – | – | – | |
| 4.1% | 4.5% | 11.7% | 15.2% | 57.8% | 1.0% | 1.8% | 3.0% | 0.8% | 0.6% | 0.9% | 0.6% | |
| 84.0% | 75.7% | 61.2% | 57.7% | -12.1% | 96.2% | 90.9% | 90.1% | 91.6% | 95.4% | 96.7% | 93.7% | |
| -350.8% | -461.2% | -646.5% | -866.8% | -1,880.1% | -95.8% | -114.7% | -132.8% | -163.3% | -78.7% | -91.8% | -109.2% | |
| 29.9% | 42.6% | 57.3% | 85.4% | 202.9% | 16.5% | 95.0% | 101.3% | 113.1% | 52.0% | 99.4% | 106.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.